Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Clorox Co    CLX

CLOROX CO (CLX)
Mes dernières consult.
Most popular
Delayed Quote. Delayed  - 07/24 10:02:11 pm
131.32 USD   -0.70%
07/20 CLOROX : Pediatric patients get special delivery
07/17 CLOROX CO : ex-dividend day
07/11 THE CLOROX COMP : and DonorsChoose.org Partnership Simplifies Back-t..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

The Clorox Company : Refutes Silent Spring Institute's Study on Our Consumer Products

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/08/2012 | 03:26pm CEST

We have reviewed the findings of Silent Spring's study claiming some U.S. consumer products contain endocrine-disrupting and asthma-related ingredients.

Product safety is a top priority at The Clorox Company and our company guidelines prohibit using endocrine-disrupting ingredients in our products. For those household products containing fragrance ingredients some consider to be asthma related, these ingredients are present at such low concentrations they do not cause irritation or trigger asthma when used as directed.

Our highly skilled scientists evaluate each product's safety, efficacy and regulatory compliance before it makes it to store shelves. Our safety assessments begin with analysis of each of the materials that go into making the product. This includes consideration of short-term and long-term impact from all types of exposures, including incidental or accidental, and routes of exposure such as skin, eye, ingestion and inhalation. Our safety evaluation also includes the assessment of fragrances, dyes, and preservatives, and other proprietary ingredients, in our formulations.

Clorox voluntarily discloses all ingredients for our U.S. and Canadian household cleaning and disinfecting products through our industry-leading initiative, Ingredients Inside (www.IngredientsInside.com), which is available on our corporate web site and mobile platforms.

For more information on our product stewardship guidelines, visit http://www.thecloroxcompany..


share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CLOROX CO
07/20 CLOROX : Pediatric patients get special delivery
07/17 CLOROX CO : ex-dividend day
07/14 CLOROX CO : Dividend Coverage: This Consumer Products Maker has Raised Dividend ..
07/11 THE CLOROX COMPANY : and DonorsChoose.org Partnership Simplifies Back-to-School ..
07/05 CLOROX : Announces Aug. 3 Webcast of Fourth-Quarter and Fiscal Year 2017 Results
06/30 CLOROX : Global Cedarwood Oil Terpenes Sales Market 2017 - PP Sheth, Trends, Clo..
06/22 COMCAST : Philly CEOs make Glassdoor's top boss list
06/21 CLOROX : CEO Benno Dorer Earns Top Spot on Glassdoor’s Highest-Rated CEOs ..
06/21 CLOROX : CEO Benno Dorer Earns Top Spot on Glassdoor's Highest-Rated CEOs List f..
06/13 CLOROX : Introducing New and Improved Clorox Healthcare® Hydrogen Peroxide Clean..
More news
News from SeekingAlpha
07/24 A REVIEW OF THE DIVIDEND HOUSE PORTF : Time For A House Inspection
07/24 THE IM-CAPITAL STRENGTH 20-STOCK UNI : Performance And Holdings Update
07/21 Vanguard Prepares To Destroy The S&P 500 Again
07/17 How To Harden Your Dividend Growth Portfolio Against Dividend Cuts
07/13 Stocks Going Ex-Dividend The Third Week Of July
Financials ($)
Sales 2017 5 970 M
EBIT 2017 1 118 M
Net income 2017 698 M
Debt 2017 1 802 M
Yield 2017 2,46%
P/E ratio 2017 24,74
P/E ratio 2018 23,05
EV / Sales 2017 3,13x
EV / Sales 2018 3,02x
Capitalization 16 914 M
Chart CLOROX CO
Duration : Period :
Clorox Co Technical Analysis Chart | CLX | US1890541097 | 4-Traders
Technical analysis trends CLOROX CO
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 17
Average target price 133 $
Spread / Average Target 1,3%
EPS Revisions
Managers
NameTitle
Benno O. Dorer Chairman & Chief Executive Officer
Dawn C. Willoughby Chief Operating Officer & Executive VP
Stephen M. Robb Chief Financial Officer & Executive Vice President
Manjit Singh Chief Information Officer & Senior Vice President
Robert W. Matschullat Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
CLOROX CO10.18%16 914
RECKITT BENCKISER10.70%69 860
UNILEVER INDONESIA TBK PT--.--%27 668
CHURCH & DWIGHT CO., INC.19.48%13 161
LION CORP24.69%6 433
KOBAYASHI PHARMACEUTICAL CO LTD38.12%5 112